Add to Favorites Newsroom RSS Share
fb-shareUniversity of Texas M. D. Anderson Cancer Center
Houston, TX USA

Our News on Newswise


Study finds melanoma brain metastases are immunosuppressive with treatment-resistant metabolism

Melanoma tumors that have spread to the brain are equipped to thwart immunotherapies and targeted therapies that succeed against tumors growing in other sites. Researchers at The University of Texas MD Anderson Cancer Center report in Cancer...
20-Feb-2019 8:05 AM EST Add to Favorites


Small cell lung cancer may respond to combination of immunotherapy and DNA damage repair inhibitors

Researchers at The University of Texas MD Anderson Cancer Center have discovered that a combination of immune checkpoint blockade and targeted therapies that block normal DNA damage repair (DDR) achieved significant tumor regression in mouse models...
17-Feb-2019 12:05 AM EST Add to Favorites

Immunotherapy Combination Generates Responses Against Castration-Resistant Metastatic Prostate Cancer

Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results from a clinical trial led by investigators at MD Anderson
14-Feb-2019 4:05 PM EST Add to Favorites


New therapeutic target found for aggressive pediatric cancers with few treatment options

Researchers at The University of Texas MD Anderson Cancer Center have discovered that malignant rhabdoid tumors (MRT), a rare pediatric cancer without effective treatments, may be sensitive to drugs that block the cancer cell’s ability to dispose...
10-Feb-2019 11:00 AM EST Add to Favorites

MD Anderson supports World Cancer Day call for action to end cancer

As an institution devoted to eliminating cancer for patients in Texas, the nation and around the world, The University of Texas MD Anderson Cancer Center is proud to uphold the mission of World Cancer Day, Feb.4, to unite the global population...
4-Feb-2019 7:05 AM EST Add to Favorites


MD Anderson study shows FGL2 protein may be an effective target for glioblastoma

Glioblastoma (GBM) does not attract robust T cell immune responses. FGL2 is highly expressed in GBM and when present in tumor cells, controls a specialized group of dendritic cells which activates T cells.
25-Jan-2019 1:00 PM EST Add to Favorites

MD Anderson Cancer Center and Dragonfly Therapeutics announce strategic collaboration to take new immunotherapy candidates into clinical trials

The University of Texas MD Anderson Cancer Center and Dragonfly Therapeutics, Inc., today announced a strategic collaboration to bring Dragonfly’s TriNKET™ (tri-specific natural killer cell engager therapy) immunotherapy drug candidates to...
15-Jan-2019 9:05 AM EST Add to Favorites


Complication rates and costs of invasive lung cancer diagnostic tests may be higher than anticipated

Complication rates following invasive diagnostic procedures for lung abnormalities were twice as high in community settings compared to those reporter in lung screening trials, according to an MD Anderson study.
10-Jan-2019 12:05 PM EST Add to Favorites

see all news

Our Experts on Newswise


Mastectomy Plus Reconstruction Has Highest Rate of Complication, Complication-Related Costs of Guideline-Concordant Therapies for Early Breast Cancer

In a review of guideline-concordant treatment modalities for women with early stage breast cancer, mastectomy and reconstruction had the highest rate of complications and complication-related costs, regardless of age.
27-Sep-2016 3:05 PM EDT


Can Gender Play a Role in Determining Cancer Treatment Choices?

It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a molecular level has been poorly understood.
9-May-2016 12:00 PM EDT


MD Anderson Study Reveals New Insight Into Tumor Progression

Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT


Poor Survival Among Colorectal Cancer Patients Tied to Biomarker CSN6

A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT


MD Anderson Study Predicts New Hepatitis C Drugs Will Place a Dramatic Financial Strain on the Health Care System

The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT

MD Anderson Joins CATCH Global Foundation to Boost Child Health, Prevent Cancer in Later Years

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST

MD Anderson Energy Balance Expert Available for Obesity, Cancer Stories

30-Oct-2013 8:10 PM EDT

MD Anderson Obesity and Cancer Expert Researches Food Addiction

30-Oct-2013 8:00 PM EDT

see all experts

Our YouTube Videos


About section not configured. Is this your member page? Login to edit, or contact to configure this module.


Clayton Boldt


Katrina Burton
Senior Communications Specialist


Leslie Friedman
Communications professional


Scott Merville
Program Manager


Julie Penne
Assistant Director


Allison Schaffer
Senior Communications Specialist


Twitter twitter-icon

Chat now!